PharmacovigilanceOfficial
AIFA: Italy's public pharmaceutical spending hits €13.42bn in first half of 2026
🇮🇹 AIFA · Thu 19 Nov 2026
AIFA's monitoring report puts January–June 2026 public drug spending at 19.07% of the provisional national health fund figure communicated by the Ministry of Health.
Italy's medicines agency AIFA has published its monitoring report on pharmaceutical expenditure for January to June 2026. Total public spending, covering convenzionata (retail reimbursed prescriptions), direct purchases and oxygen, came to €13,417.6 million.
Subscribe to keep reading
$4.99 / month
- Every article, analysis and opinion piece on VigiEye and CompePharma
- One subscription for both sites, cancel any time
or
Article written by VigiEye from the official source (AIFA). AI-assisted; check the source before acting.
More Pharmacovigilance
All →
FDA early alert: Heraeus Medevio recalls vascular guidewires over hydrophilic coating clumping risk
🇺🇸 FDA MedWatch · Fri 20 Nov 2026
EMA publishes PSUSA outcome for ibuprofen medicines, concluding with a variation
🇪🇺 EMA · Fri 20 Nov 2026
EMA publishes PSUSA outcome for nationally authorised split-virion inactivated influenza vaccines, recommending a variation
🇪🇺 EMA · Fri 20 Nov 2026
CMS proposes Medicare Advantage rule to ease market entry and widen beneficiary choice
🇺🇸 CMS · Fri 20 Nov 2026
CMS issues proposed rule on 2028 Medicare Advantage and Part D changes
🇺🇸 CMS · Fri 20 Nov 2026
FDA warns Florida clinical investigator over consent failings in INSTI HIV self-test study
🇺🇸 FDA CBER · Fri 20 Nov 2026